Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression

American Journal of Pathology

Volumn 154, Issue 2, 1999, Pages 375-384

  Nör, Jacques E ^a   Christensen, Joan ^a   Mooney, David J ^a   Polverini, Peter J ^a  

^a UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL SURVIVAL; CONTROLLED STUDY; ENDOTHELIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; VASCULAR ENDOTHELIUM;

EID: 0032963472     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65284-4     Document Type: Article

References (37)

1. Ferrara N: Vascular endothelial growth factor. Eur J Cancer 1996, 32A:2413-2422
2. Plate KH, Breiser G, Weich HA, Risau W: Vascular endothelial growth factor is a potential tumor angiogenesis factor in vivo. Nature 1992, 359:845-848
3. Hashimoto M, Ohsawa M, Ohnishi A, Naka N, Hirota S, Kitamura Y, Aosaza K: Expression of vascular endothelial growth factor and its receptor mRNA in angiosarcoma. Lab Invest 1995, 73:859-863
4. Benjamin LE, Keshet E: Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc Natl Acad Sci USA 1997, 94:8761-8766
5. Brown LF, Yeo KY, Berse B, Yeo TK, Senger DR, Dvorak HF, Van de Water L: Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 1992, 176:1375-1379
6. Berse B, Brown LF: Van de Water L, Dvorak HF, Senger DR: Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell 1992, 3:211-220
7. 206. Mol Biol Cell 1998, 9:875-884
8. Ferrara N, Wilner J, Burton T: Aortic smooth muscle cells express and secrete vascular endothelial growth factor. Growth Factors 1991, 5:141-148
9. Brown LF, Berse B, Jackman RW, Tognazzi K, Guidi A, Dvorak HF, Senger DR, Connoly J, Schnitt S: Expression of vascular permeability factor (vascular endothelial growth factor) and its receptor in breast cancer. Hum Pathol 1995, 26:86-91
10. Folkman J, Shing Y: Angiogenesis. J Biol Chem 1992, 267:10931-10934
11. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989, 246:1306-1309
12. Dvorak HF, Brown LF, Detmar M, Dvorak AM: Vascular permeability factor/vascular endothelial growth factor, vascular hyperpermeability, and angiogenesis. Am J Pathol 1995, 146:1029-1039
13. Mandriota SJ, Pepper MS: Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibroblast growth factor. J Cell Sci 1997, 110:2293-2302
14. Alon T, Hemo I, Itin A, Pe'ee J, Stone J, Keshet E: Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nature Med 1995, 1:1024-1028
15. Spyridopoulos I, Brogi E, Kearney M, Sullivan AB, Cetrulo C, Isner JM, Losordo DW: Vascular endothelial growth factor inhibits endothelial cell apoptosis induced by tumor necrosis factor-α: balance between growth and death signals. J Mol Cell Cardiol 1997, 29:1321-1330
16. Watanabe Y, Dvorak HF: Vascular permeability factor/vascular endothelial growth factor inhibits anchorage disruption induced apoptosis in microvessel endothelial cells by inducing scaffold formation. Exp Cell Res 1997, 233:340-349
17. Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994, 124:1-6
18. Thompson C: Apoptosis in the pathogenesis and treatment of disease. Science 1995, 267:1456-1462
19. Nuñez G, Clarke MF: The Bcl-2 family of proteins: regulators of cell death and survival. Trends Cell Biol 1994, 4:399-403
20. Korsmeyer SJ: Regulators of cell death. Trends Genet 1995, 11:101-105
21. Kroemer G: The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nature Med 1997, 3:614-620
22. Kondo S, Yin D, Aoki T, Takahashi JA, Morimura T, Takeuchi J: Bcl-2 gene prevents apoptosis of basic fibroblast growth factor-deprived murine aortic endothelial cells. Exp Cell Res 1994, 213:428-432
23. Gerber HP, Dixit V, Ferrara N: Vascular endothelial growth factor induces expression of the anti-apoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J Biol Chem 1998, 273:13313-13316
24. Villaschi S, Nicosia R: Paracrine interactions between fibroblasts and endothelial cells in a serum-free coculture model: modulation of angiogenesis and collagen gel contraction. Lab Invest 1994, 71:291-299
25. DiPietro LA, Nebgen DR, Polverini PJ: Modulation of in vitro angiogenesis by genetic manipulation of endothelial cell thrombospondin. J Vasc Res 1994, 31:178-185
26. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992, 119:493-501
27. Gong J, Traganos F, Darzynkiewiez Z: A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry. Anal Biochem 1994, 218:314-319
28. Mitra RJ, Wrone-Smith T, Simonian P, Foreman KE, Nuñez G, Nickoloff BJ: Apoptosis in keratinocytes is not dependent on induction of differentiation. Lab Invest 1997, 76:99-107
29. Lomo J, Smeland EB, Krajewski S, Reed JC, Blomhoff HK: Expression of the Bcl-2 homologue Mcl-1 correlates with survival of peripheral blood B lymphocytes. Cancer Res 1996, 56:40-43
30. Miller AD, Miller DG, Garcia JV, Lynch CM: Use of retroviral vectors for gene transfer and expression. Methods Enzymol 1993, 217:581-599
31. Mooney DJ, Sano K, Kaufmann PM, Majahod K Scloo B, Vacanti JP, Langer R: Long-term engraftment of hepatocytes transplanted on biodegradable polymer sponges. J Biomed Mater Res 1997, 37:413-420
32. Strieter RM, Polverini PJ, Arenberg DA, Walz A, Opdenakker G, van Damme J, Kunkel SL: Role of C-X-C chemokines as regulators of angiogenesis in lung cancer. J Leukoc Bol 1995, 57:752-762
33. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP, Wang X: Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 1997, 275:1129-1132
34. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD: The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 1997, 275:1132-1136
35. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S: A caspase-activated DNase that degrades DNA during apoptosis and its inhibitor ICAD. Nature 1998, 391:43-50
36. Vermeulen PB, Gasparini G, Fox SB, Toi M, Martin L, Pezzella F, Viale G, Weidner N, Harris AL, Dirix LY: Quantification of angiogenesis in solid human tumors: an international consensus on the methodology and criteria of evaluation. Eur J Cancer 1996, 32A:2474-2484
37. Polverini PJ: The pathophysiology of angiogenesis. Crit Rev Oral Biol Med 1995, 6:230-247